Current and New Concepts in the Biology and Treatment of Head and Neck Cancer
Saturday, October 18
Continuing Medical Education activity
This full-day course will focus on recent advances and therapeutic management of head and neck cancer. Through lecture and case discussion, specialists in the field will address a range of head and neck cancer diagnoses, including thyroid cancer, nasopharyngeal cancer, oropharynx cancer, non-melanoma skin cancer, and salivary gland cancer. Topics for discussion with include clinical trials, palliative care, personalized therapy, immunotherapy, reconstructive strategies, and treatment of swallowing complications specific to head and cancer.
At the completion of this course, attendees will be able to:
- summarize the benefits of implementing a combined modality approach that integrates surgery, chemotherapy, and radiation to achieve best outcomes;
- describe the role and impact on treatment of HPV-related oropharynx cancer;
- discuss the management of less common head and neck cancer subtypes such as non-melanoma skin cancer, nasopharynx cancer, and thyroid cancer.
This course is intended for oncologists (medical, surgical, and radiation), otolaryngologists/head and neck surgeons, oral surgeons, oncology nurse practitioners, and other interested clinicians.
Dana-Farber Cancer Institute
The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
For complete course information and to register, visit: www.dfbwcc.org/cme or call 800-553-3787.
No recent activity